Simple Search:

Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.


Citation

Noorjahan Banu Mohammed Alitheen. (2010) Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy. .

Abstract / Synopsis

This invention provides a method for immune activation of human peripheral blood mononuclear cells (PBMC) by treatment with immunogens derived from New Castle Disease virus (NDV). The invention describes a method of activation of PBMC by NDV, the activated PBMCs produced by the inventive method as well as pharmaceutical compositions and vaccines comprising the same. Further embodiments of the invention relate to the use of NDV derived immunogens and the inventive activated PBMCs in immunetheraphy of proliferative diseases - such as cancer. The invention finally provides a method for killing target cells, preferably cancer cells, by co-culturing the target cells together with the inventive activated PBMCs.


Download File

Full text not available from this repository.

Additional Metadata

Item Type: Patent
Application Number: PI2010700088
Filing Date: 2010-11-30
Divisions: Faculty of Biotechnology and Biomolecular Sciences
Keywords: Newcastle disease; Peripheral blood mononuclear cell; Virus; Cancer.
Depositing User: Nurul Ainie Mokhtar
Date Deposited: 03 Sep 2014 14:30
Last Modified: 03 Sep 2014 14:30
URI: http://psasir.upm.edu.my/id/eprint/32058
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item